Author

Sarah M. Sterling

Harvard UniversityORCID 0000-0003-0017-0408Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Andrew C. KruseiD· 1 shared Conor T. McMahoniD· 1 shared Dean P. Staus· 1 shared Genevieve R. NemethiD· 1 shared Haoran JiangiD· 1 shared Howard A. RockmaniD· 1 shared Huixin XuiD· 1 shared Jihee Kim· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Andrew C. KruseORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyNature Chemical BiologyPeer-reviewedMay 14, 2024

Antibodies Expand the Scope of Angiotensin Receptor Pharmacology

Meredith A. Skiba, Sarah M. Sterling, Shaun Rawson…·Andrew C. Kruse

This study develops nanobody antagonists against the AT1R receptor, showing they can selectively bind and modulate the receptor with tunable ligand selectivity.

37 citationstop 4%

humanexperimental assay

𝕏 PostBluesky